Immunis Chairman Dr. Hans Keirstead to Present at Innovative Therapies Days in France

Immunis, Inc., a private biotech pioneering cellular secretome treatments to address age and disease-related immune decline, is pleased to announce that its Chairman, Dr. Hans Keirstead, will be taking center stage at

Related Keywords

France ,Hans Keirstead ,Immunis Inc ,Innovative Therapies Days ,Immuni Phase ,